Category: <span>Cancer</span>

Home / Cancer
Post

Natural molecule appears to shut off cancer cells’ energy source

The Warburg Effect describes a phenomenon in which cancer cells voraciously consume glucose for energy—something scientists have long known, yet have had little success exploiting as a way to stunt tumor growth. Now researchers at Duke Cancer Institute have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural...

September 19, 2017September 19, 2017by In Cancer
Post

Research discovers potential new Rx target for colon cancer

Genetic research conducted at LSU Health New Orleans School of Medicine and Stanley S. Scott Cancer Center demonstrated for the first time that a novel protein can cause normal cells in the lining of the colon to become malignant, grow and spread, as well as take on the characteristics of stem cells. The work, which...

September 12, 2017September 12, 2017by In Cancer
Post

Cancer survivors who quit smoking sooner can live longer

Lung cancer survivors who quit smoking within a year of diagnosis will live for longer than those who continue to smoke, according to new research led by the Universities of Birmingham and Oxford. The findings also revealed that general practitioners are comparatively less likely to intervene and offer stop-smoking support to cancer patients, than they are to...

September 12, 2017September 12, 2017by In Cancer
Post

Australian researchers say they can stop melanoma spreading

Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma.    Researchers say a combination of new treatments can stop the world’s deadliest form of skin cancer—melanoma—in its tracks and halt its spread to other organs. Results from two international drug trials conducted by the Sydney-based Melanoma Institute Australia have proved successful...

September 12, 2017September 12, 2017by In Cancer
Post

‘Triggers’: A new tool to assess cancer patients’ palliative needs

A new tool to identify patients who would benefit from early palliative care will be presented at the ESMO 2017 Congress in Madrid. (1) The so-called “Triggers” tool, developed by the London Cancer Alliance to help clinicians in the UK recognise patients who need an early referral to specialist palliative care, has been successfully piloted at...

September 12, 2017September 12, 2017by In Cancer
Post

Zinc Transporter Key to Fighting Pancreatic Cancer And More

EAST LANSING, Mich. – When trace elements rise to toxic levels, bad things happen. Patients suffering from Alzheimer’s and Parkinson’s disease harbor significantly higher levels of zinc and iron in their brains than healthy patients. Those with pancreatic cancer have an unusually high amount of a specific zinc transporter. So, controlling those levels could be...

September 12, 2017September 12, 2017by In Cancer
Post

New study finds improved vaccine that protects against nine types of HPV is highly effective

Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts.    Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus (HPV) vaccines has significantly...

September 12, 2017September 12, 2017by In Cancer
Post

Inactivated vaccinia virus effective against advanced cancers alone or combined with immune checkpoint inhibitors

Modified vaccinia virus Ankara (MVA), a poxvirus, was found to be safe when administered in an inactivated form in mice, and delivering it into the tumor in addition to systemic delivery of an immune checkpoint inhibitor yielded synergistic antitumor effects in mice with large tumors and those with multiple tumors, according to data presented at...

September 12, 2017September 12, 2017by In Cancer
Post

Zika virus could be used to treat brain cancer patients, study suggests

Recent outbreaks of Zika virus have revealed that the virus causes brain defects in unborn children. But in a study to be published September 5 in The Journal of Experimental Medicine, researchers from Washington University School of Medicine in St. Louis and the University of California, San Diego report that the virus could eventually be used...

September 12, 2017September 12, 2017by In Cancer
Post

New way to kill cancer is better than chemotherapy: Treatment will use a patient’s immune system to wipe out all of a tumour’s cells

Scientists say they have found a way to prompt the immune system into helping  They found a protein which enables chemotherapy to kill tumour cells ‘silently’ The new form of chemotherapy acts as sort of red flag to the immune system  The drug could be available to Britain’s 356,000 cancer patients within decade Scientists have new...

September 5, 2017September 5, 2017by In Cancer